← Leaderboards
Hyung L Kim
Roswell Park Cancer Institute Corp
$6,429,617
Attributed
$9,778,513
Total exposure
5
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1M · FY2007–25$2M$1.5M$1M$500K$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$9,778,513 · 5
By mechanism
R01$8,967,453 · 4
K23$811,060 · 1
Top collaborators
- Beatrice S Knudsen6 shared
- Debiao Li5 shared
- Patricia Ann Thompson-Carino3 shared
Most similar at Roswell Park Cancer Institute Corp
Same institution · by research overlap
- Wei Zheng$71,826,577
- Gary A Giovino$1,035,656
- Kenneth W Gross$7,053,357
Others in their field
Top investigators on “Diagnosis”
- David Heimbrook · Leidos Biomedical Research, Inc.$590,717,255
- Bambra Strokes · Ppd Development Lp$526,656,217
- Leonard Freedman · Leidos Biomedical Research, Inc.$337,858,596
- Richard K. Wilson · Washington University$297,645,172
- Sharon A Nachman · Johns Hopkins University$212,395,175
- Carol Nesel · Westat$188,148,170
Research focus
DiagnosisNewly DiagnosedMolecularMalignant NeoplasmsRadiationTumorClinical TrialsEnrollmentOperative Surgical ProceduresBaseCessation Of LifeHistologicImmuneResponseImmune SystemMetastatic Renal Cell CancerHypoxiaProteinsBinding (Molecular Function)Interleukin-2Kidney NeoplasmsClear CellChemotherapyImmunotherapy
Grant awards (28)
Intensive cholesterol-lowering intervention and anti-tumor immunity modeled in prostate cancer$692,001
R01 · FY2025 · CA · contact PI
Intensive cholesterol-lowering intervention and anti-tumor immunity modeled in prostate cancer$657,403
R01 · FY2024 · CA · contact PI
Intensive cholesterol-lowering intervention and anti-tumor immunity modeled in prostate cancer$692,001
R01 · FY2023 · CA · contact PI
High resolution volumetric MRI for prostate cancer active surveillance$380,240
R01 · FY2021 · CA · contact PI
High resolution volumetric MRI for prostate cancer active surveillance$380,240
R01 · FY2020 · CA · contact PI
High resolution volumetric MRI for prostate cancer active surveillance$369,830
R01 · FY2019 · CA · contact PI
Qualifying Multi-Transcript Signatures for Active Surveillance of Prostate Cancer$548,878
R01 · FY2018 · CA · contact PI
High resolution volumetric MRI for prostate cancer active surveillance$379,039
R01 · FY2018 · CA · contact PI
Qualifying Multi-Transcript Signatures for Active Surveillance of Prostate Cancer$95,249
R01 · FY2018 · CA · contact PI
Qualifying Multi-Transcript Signatures for Active Surveillance of Prostate Cancer$495,841
R01 · FY2017 · CA · contact PI
High resolution volumetric MRI for prostate cancer active surveillance$373,652
R01 · FY2017 · CA · contact PI
Qualifying Multi-Transcript Signatures for Active Surveillance of Prostate Cancer$527,589
R01 · FY2016 · CA · contact PI
Qualifying Multi-Transcript Signatures for Active Surveillance of Prostate Cancer$500,277
R01 · FY2015 · CA · contact PI
Qualifying Multi-Transcript Signatures for Active Surveillance of Prostate Cancer$605,552
R01 · FY2014 · CA · contact PI
Expression profiling of renal cell carcinoma utilizing tissue from CALGB 90206$353,636
R01 · FY2013 · CA · contact PI
Expression profiling of renal cell carcinoma utilizing tissue from CALGB 90206$343,754
R01 · FY2012 · CA · contact PI
Heat Shock Protein Vaccine Targeting Carbonic Anhydrase IX in Renal Cell Carcinom$146,059
K23 · FY2011 · CA · contact PI
Expression profiling of renal cell carcinoma utilizing tissue from CALGB 90206$55,462
R01 · FY2011 · CA · contact PI
Expression profiling of renal cell carcinoma utilizing tissue from CALGB 90206$429,934
R01 · FY2010 · CA · contact PI
Heat Shock Protein Vaccine Targeting Carbonic Anhydrase IX in Renal Cell Carcinom$147,948
K23 · FY2010 · CA · contact PI
Expression profiling of renal cell carcinoma utilizing tissue from CALGB 90206$507,942
R01 · FY2009 · CA · contact PI
Heat Shock Protein Vaccine Targeting Carbonic Anhydrase IX in Renal Cell Carcinom$128,534
K23 · FY2009 · CA · contact PI
Heat Shock Protein Vaccine Targeting Carbonic Anhydrase IX in Renal Cell Carcinom$73,209
K23 · FY2009 · CA · contact PI
Expression profiling of renal cell carcinoma utilizing tissue from CALGB 90206$34,078
R01 · FY2009 · CA · contact PI
Heat Shock Protein Vaccine Targeting Carbonic Anhydrase IX in Renal Cell Carcinom$19,414
K23 · FY2009 · CA · contact PI
Expression profiling of renal cell carcinoma utilizing tissue from CALGB 90206$544,855
R01 · FY2008 · CA · contact PI
Heat Shock Protein Vaccine Targeting Carbonic Anhydrase IX in Renal Cell Carcinom$147,948
K23 · FY2008 · CA · contact PI
Heat Shock Protein Vaccine Targeting Carbonic Anhydrase IX in Renal Cell Carcinom$147,948
K23 · FY2007 · CA · contact PI